News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
HENGRUI PHARMA's RSS0393 Lotion Approved for Clinical Trials
HENGRUI PHARMA (01276.HK) announced that its subsidiary Ruishi Biopharmaceutical (literal translation of "瑞石生物醫藥") has received ...
Reset
Send
The window will close in 5 seconds
HENGRUI PHARMA's RSS0393 Lotion Approved for Clinical Trials
Close
Recommend
1
Positive
3
Negative
3
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Gold ETF share!

HENGRUI PHARMA (01276.HK)  -0.650 (-0.979%)    Short selling $66.91M; Ratio 27.140%   announced that its subsidiary Ruishi Biopharmaceutical (literal translation of "瑞石生物醫藥") has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration for RSS0393 lotion, and will commence clinical trials in the near term.

RSS0393 is a lotion containing a PDE4 small-molecule inhibitor. After topical application, it alleviates tissue damage and inflammation by inhibiting PDE4 activity in various intracellular pathways.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-15 16:25.)

Related NewsCiti: Fundamentals of China Healthcare Sector Continue to Improve; Top Picks WUXI APPTEC (02359.HK), WUXI BIO (02269.HK), ALI HEALTH (00241.HK)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.